Dr. Andrew Spiros Dorizas, MD

Dr. Dorizas practices at UMiami Medicine - Dermatology in Miami, Florida.

Dr. Dorizas' NPI, 1336506260, was assigned on January 22, 2016. Dr. Dorizas graduated from Albert Szent - Gyorgi Medical University in 2010. Dr. Dorizas holds Florida license ME144623.

Dr. Dorizas' primary practice is UMiami Medicine - Dermatology, at 1444 NW 9th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-7688.

Dr. Dorizas' primary practice is UMiami Medicine - Dermatology in Miami, Florida. Dr. Dorizas is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Dorizas to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dorizas practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Dorizas' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dorizas is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Dorizas' licenses on file in 2 states: Florida and Alaska.

Dmand AI lists acne, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes, psoriasis and rash among the conditions Dr. Dorizas treats.

CMS data shows 3,075 Medicare services from Dr. Dorizas across 20 procedure codes in 2024, for 812 Medicare patients. Medicare paid $238,335 for them. Every service was in an office.

CMS counts 812 Medicare patients who saw Dr. Dorizas in 2024. The largest group is 65 to 74, with 399 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dorizas' median patient age at 64, with 54% women.

In 2024, Dr. Dorizas wrote 1,154 Medicare Part D claims for 409 patients. 87% of them were for generic drugs. CMS names the drug for 910 of them, across 21 drugs with 11 or more claims each, at $318,516 in total drug cost. In 2023, CMS named 584 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 31 out of 100 for Dr. Dorizas for performance year 2024, reported individually. Dr. Dorizas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 657 procedures of skin biopsy by Dr. Dorizas, more than 97% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Dorizas, published from 2017 to 2018. 2017 was the busiest year, with 2. The most frequent topics are Cosmetic Techniques, Skin Aging and Esthetics. Dr. Dorizas has published most often in J Drugs Dermatol. Dr. Dorizas' most frequent co-authors are Neil Scott Sadick, MD and Aria Shafai, MD.

CMS Open Payments shows 1,543 general payments to Dr. Dorizas from 43 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 69% of the total. Janssen Pharmaceuticals, Inc paid the most, $265,006.

Dr. Dorizas graduated from Albert Szent - Gyorgi Medical University in 2010.

Dr. Dorizas is in network with 11 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.